Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Vectura Group

www.vectura.com Vectura Group

One Prospect West
Chippenham
Wiltshire
SN14 6FH
United Kingdom

+44 1249 667700

Activities

Manufacturing | Drug Delivery | Research & Development | Pharmaceutical

Related Companies

  • Gerresheimer
  • Romaco Holding GmbH
  • Lonza
  • Titan Enterprises
  • Icrom SRL
  • TrakCel
  • Huber
  • Nanoform
  • GEA Pharma and Healthcare
  • Merck Life Science KGaA
  • Starlab
  • Adare Pharma Solutions
  • Beamex
  • Edwards Vacuum
  • Burkert Fluid Control Systems
  • Envair Technology
  • Biopharma Group
  • Asynt
  • PCI Pharma Services
  • Owen Mumford

Related Content

Vectura’s $62.7m inhalation centre granted planning permission
Vectura’s $62.7m inhalation centre granted planning permission
Optimising dry powder inhaler programmes through formulation
Optimising dry powder inhaler programmes through formulation
Vectura to provide development services for brain injury drug
Vectura to provide development services for brain injury drug
Free webcast: Inhaled Bioequivalence - A Broader View of Product Development
Free webcast: Inhaled Bioequivalence - A Broader View of Product Development
Accelerating excipient development for inhalable dosage forms with QbD
Accelerating excipient development for inhalable dosage forms with QbD
Vectura expanding manufacturing capabilities in Chippenham
Vectura expanding manufacturing capabilities in Chippenham
Vectura earns $11m milestone with Hikma generic launch
Vectura earns $11m milestone with Hikma generic launch
Vectura expands HPAPI capabilities in the UK
Vectura expands HPAPI capabilities in the UK
Vectura signs agreement with Kinaset to develop asthma treatment
Vectura signs agreement with Kinaset to develop asthma treatment
Status update on ANDA for generic Advair Diskus (VR315 [US])
Status update on ANDA for generic Advair Diskus (VR315 [US])
Vectura partners with Monash University on inhaled oxytocin
Vectura partners with Monash University on inhaled oxytocin
Delivering success for inhaled drug development programmes
Delivering success for inhaled drug development programmes
Vectura Group names new Chief Commercial Officer
Vectura Group names new Chief Commercial Officer
Opening the aperture: taking a wider view of the inhalables market
Opening the aperture: taking a wider view of the inhalables market
Hikma announces agreement with Vectura to develop generic salmeterol for the US market
Hikma announces agreement with Vectura to develop generic salmeterol for the US market
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company